Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 11, 2002
[Fibromyxoid tumor of the bladder: report of 3 cases]Alexandre de la Taille, Nicolas Thiounn, Frédérique Tissier, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2005
[Bellini renal cell carcinoma. Diagnosis and treatment]Morgan Roupret, Michaël Peyromaure, Vincent Hupertan, et al.Urology|August 15, 2006
Management of a malignant urinary fistula by ureteral embolization with coilsDelphine Amsellem-Ouazana, François Cornud, Sophie Conquy, et al.World Journal of Urology|September 3, 2014
Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapyAlexandra Masson-Lecomte, Evanguelos Xylinas, Morgane Bouquot, et al.Mucosal Immunology|May 13, 2022
CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanismsEmmanuel Cohen, Jammy Mariotton, Flore Rozenberg, et al.Mucosal Immunology|April 21, 2026
Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cellsCaio César Barbosa Bomfim, Hugo Génin, Jammy Mariotton, et al.Vaccines|March 30, 2023
Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World StudyJean-François Rossi, Emmanuel Bonnet, Christel Castelli, et al.Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanismsJammy Mariotton, Emmanuel Cohen, Aiwei Zhu, et al.Journal of Andrology|October 22, 2011
A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutationRossella Libé, Amato Fratticci, Najiba Lahlou, et al.Anti-Cancer Drugs|September 16, 2005
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbiditiesOlivier Mir, Jérôme Alexandre, Stanislas Ropert, et al.Pageof 11